← Back to search
DREXEL UNIVERSITY
PHILADELPHIA, PA, 19104
UnclaimedClaim this profile (free)
Prime contracting experience
9 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services Food and Drug Administration | BAA PMQWP 353 - MACHINE-LEARNING BASED HETEROGENEOUS TREATMENT EFFECT MODELS FOR PRIORITIZING PRODUCT-SPECIFIC GUIDANCE DEVELOPMENT | — | $494,060 | Sep 21, 2026 | Sep 27, 2022 – Sep 29, 2025 |
| Prime | Department of Defense Department of the Army | SERDP PROJECT ER19-1032 ANSDU | — | $1,436,515 | May 14, 2026 | Sep 10, 2019 – Sep 10, 2025 |
| Prime | Department of Defense Department of the Navy | TUITION AND FEES PA, DREXEL UNIVERSITY | N0018925GZ081USAspending | $267,466 | Apr 2, 2026 | Jan 30, 2026 – Jun 30, 2026 |
| Prime | Department of Health and Human Services Food and Drug Administration | PROCURE A STUDY TO UNDERSTAND HOW MEDICAL IMPLANTATION ALTERS LOCAL AND/OR SYSTEMIC IMMUNE RESPONSE RELATIVE TO IMPLANTED METAL-ALLOW DEVICES. | — | $499,990 | Jun 17, 2025 | Aug 11, 2023 – Jun 17, 2025 |
| Prime | Department of Defense Department of the Army | SERDP ER18-1570 | — | $1,312,000 | Apr 28, 2025 | Aug 12, 2021 – Aug 11, 2026 |
| Prime | Department of Health and Human Services Food and Drug Administration | IMMUNOPATHOLOGY ANALYSIS OF PATIENT TISSUE SAMPLES FROM CARDIOVASCULAR AND/OR ORTHOPEDIC DEVICE IMPLANTS | — | $299,778 | Feb 2, 2024 | Sep 24, 2022 – Mar 29, 2024 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | IGF::OT::IGF RESEARCH AND DEVELOPMENT | — | $1,619,305 | Oct 17, 2022 | Sep 24, 2018 – Apr 30, 2023 |
| Prime | Department of Health and Human Services Food and Drug Administration | BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT -- DEVELOPING TOOLS BASED ON TEXT ANALYSIS AND MACHINE LEARNING TO ENHANCE PSG REVIEW EFFICIENCY | — | $545,339 | Sep 15, 2022 | Sep 23, 2019 – Sep 29, 2023 |
| Prime | Department of Defense Department of the Army | CONTRACTOR SHALL DOCUMENT SPECIFIC REQUIREMENTS AND PERFORMANCE METRICS FOR THE INSPECTION SYSTEM DETERMINED DURING KICKOFF MEETING, PROVIDE THREE (3) QUARTERLY BRIEFINGS, PROVIDE PROOF OF CONCEPT PROTOTYPE AS DESCRIBED IN TASK 4, PROVIDE ONE (1) FINAL TECHNICAL REPORT WITH DETAILS ON ANALYSES AND EXPERIMENTS PERFORMED AND PROVIDE ONE (1) JOURNAL PUBLICATION. | — | $346,047 | Jul 7, 2022 | Jun 28, 2013 – Sep 29, 2017 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Subcontracting experience
4 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Subcontractor | Department of Health and Human Services | DEVELOPMENT OF NOVEL STING PATHWAY AGONISTS AS VACCINE ADJUVANTS 1014432_DREXEL_AMND7 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541714 Parent award performance state: OR Parent award description: TO IDENTIFY NOVEL ADJUVANT CANDIDATES THAT CAN BE USED TO AUGMENT THE EFFICACY OF HUMAN VACCINES. View parent award on USAspending | — | $11 | Dec 14, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | DEVELOPMENT OF NOVEL STING PATHWAY AGONISTS AS VACCINE ADJUVANTS 1014432_DREXEL_AMND6 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541714 Parent award performance state: OR Parent award description: TO IDENTIFY NOVEL ADJUVANT CANDIDATES THAT CAN BE USED TO AUGMENT THE EFFICACY OF HUMAN VACCINES. View parent award on USAspending | — | $277,950 | Oct 11, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | DEVELOPMENT OF NOVEL STING PATHWAY AGONISTS AS VACCINE ADJUVANTS 1014432_DREXEL_AMND5 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541714 Parent award performance state: OR Parent award description: TO IDENTIFY NOVEL ADJUVANT CANDIDATES THAT CAN BE USED TO AUGMENT THE EFFICACY OF HUMAN VACCINES. View parent award on USAspending | — | $276,755 | Dec 13, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | DEVELOPMENT OF NOVEL STING PATHWAY AGONISTS AS VACCINE ADJUVANTS 1014432_DREXEL_AMND4 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541714 Parent award performance state: OR Parent award description: TO IDENTIFY NOVEL ADJUVANT CANDIDATES THAT CAN BE USED TO AUGMENT THE EFFICACY OF HUMAN VACCINES. View parent award on USAspending | — | $229,969 | Nov 17, 2021 | — – — |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced
- Department of DefenseGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.